J. Guanira

发表

The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study

T. Hallett, P. Revill, C. Caceres, 2019, The Lancet. Public health.

Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors

D. Glidden, S. Buchbinder, K. Mayer, 2019, PloS one.

HIV sero disclosure among men who have sex with men and transgender women on HIV pre-exposure prophylaxis

D. Vlahov, D. Glidden, R. Grant, 2018, AIDS care.

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

Megha L Mehrotra, D. Glidden, S. Buchbinder, 2014, The Journal of infectious diseases.

HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

D. Glidden, S. Buchbinder, R. Grant, 2014, The Lancet. Infectious diseases.

Health Survey in a Peruvian health system (ENSSA): design, methodology and general results

C. Flores, J. Guanira, Y. Hurtado-Roca, 2019, Revista de saude publica.

Towards a fair consideration of PrEP as part of combination HIV prevention in Latin America

C. Caceres, B. Grinsztejn, J. Guanira, 2016, Journal of the International AIDS Society.

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Megha L Mehrotra, D. Glidden, S. Buchbinder, 2014, The Lancet. Infectious diseases.

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

R. Grant, K. Mayer, M. Schechter, 2016, Journal of acquired immune deficiency syndromes.

The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B

R. Grant, K. Mayer, M. Schechter, 2016, Journal of acquired immune deficiency syndromes.

Hepatitis B infection and association with other sexually transmitted infections among men who have sex with men in Peru.

Jose L. Sanchez, J. Lama, Jorge Sanchez, 2010, The American journal of tropical medicine and hygiene.

Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru.

J. Carr, Jose L. Sanchez, J. Lama, 2006, The Journal of infectious diseases.

Syphilis Predicts HIV Incidence Among Men and Transgender Women Who Have Sex With Men in a Preexposure Prophylaxis Trial

D. Glidden, S. Buchbinder, R. Grant, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

Peter L. Anderson, Javier R. Lama, Kenneth H. Mayer, 2012, Science Translational Medicine.

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis

D. Glidden, R. Grant, L. Bekker, 2014, AIDS.

Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.

D. Glidden, S. Buchbinder, R. Grant, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.

D. Glidden, R. Grant, P. Defechereux, 2015, The Journal of infectious diseases.

The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men

Megha L Mehrotra, D. Glidden, R. Grant, 2018, AIDS and Behavior.

HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial

D. Glidden, R. Grant, S. Chariyalertsak, 2015, The lancet. HIV.

Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis

R. Grant, S. Chariyalertsak, J. Guanira, 2016, Journal of acquired immune deficiency syndromes.

Prevalence and Correlates of Human Herpesvirus 8 Infection Among Peruvian Men Who Have Sex With Men

W. Whittington, A. Wald, J. Lama, 2008, Journal of acquired immune deficiency syndromes.

Brief Report: Cocaine Use and Pre-exposure Prophylaxis Adherence, Care Engagement, and Kidney Function

Megha L Mehrotra, D. Glidden, R. Grant, 2019, Journal of acquired immune deficiency syndromes.

Global implementation of PrEP as part of combination HIV prevention – Unsolved challenges

S. Delany-Moretlwe, S. McCormack, T. Hallett, 2016 .

Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study

T. O. Rodrigues, M. Medina-Mora, S. Bautista-Arredondo, 2022, The lancet. HIV.

Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.

D. Glidden, S. Buchbinder, R. Grant, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study

R. Grant, K. Amico, V. Veloso, 2016, AIDS and Behavior.

Metabolic Effects of Preexposure Prophylaxis With Coformulated Tenofovir Disoproxil Fumarate and Emtricitabine

D. Glidden, S. Buchbinder, R. Grant, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Preferences for PrEP modalities among gay, bisexual, and other men who have sex with men from Brazil, Mexico, and Peru: a cross-sectional study

C. Caceres, V. Veloso, B. Grinsztejn, 2023, Therapeutic advances in infectious disease.

Study Product Adherence Measurement in the iPrEx Placebo-Controlled Trial: Concordance With Drug Detection

Kimberly A. Koester, D. Glidden, R. Grant, 2014, Journal of acquired immune deficiency syndromes.

Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.

D. Glidden, L. Benet, S. Buchbinder, 2016, The lancet. HIV.

Factors associated with long‐term HIV pre‐exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study

S. Bautista-Arredondo, C. Caceres, V. Veloso, 2022, Journal of the International AIDS Society.

Brief Report: Recovery of Bone Mineral Density After Discontinuation of Tenofovir-Based HIV Pre-exposure Prophylaxis

D. Glidden, S. Buchbinder, R. Grant, 2017, Journal of acquired immune deficiency syndromes.

Quality of Life Among Individuals with HIV Starting Antiretroviral Therapy in Diverse Resource-Limited Areas of the World

T. Flanigan, D. Celentano, L. Smeaton, 2012, AIDS and Behavior.

Anderson Efficacy in Men Who Have Sex with Men Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis

D. Glidden, S. Buchbinder, R. Grant, 2012 .

International Sexual Partnerships May Be Shaped by Sexual Histories and Socioeconomic Status.

S. Buchbinder, R. Grant, L. Bekker, 2017, Sexually transmitted diseases.

Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration Project.

D. Glidden, S. Buchbinder, R. Grant, 2019, AIDS research and human retroviruses.

Streamlining HIV Testing for HIV Preexposure Prophylaxis

D. Glidden, R. Grant, M. Schechter, 2014, Journal of Clinical Microbiology.